Specialists for Malignant peritoneal mesothelioma

38 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

David L Bartlett, MD
Rare Disease / Clinical Research
University of Pittsburgh
QC-verified PI×1
Kiran Turaga, MD
Rare Disease / Clinical Research
University of Chicago
CHICAGO, IL
QC-verified PI×2
Hedy Kindler, MD
Rare Disease / Clinical Research
University of Chicago
CHICAGO, IL
QC-verified PI×2
Robert N Taub, MD, PhD, M.D
Rare Disease / Clinical Research
Columbia University
NEW YORK, NY
QC-verified PI×3
Anne S. Tsao, MD
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
SEVERNA PARK, MD
QC-verified PI×3 1
Hedy Kindler
Rare Disease / Clinical Research
University of Chicago Comprehensive Cancer Center
CHICAGO, IL
PI×7 6
Raffit Hassan, M.D.
Rare Disease / Clinical Research
National Cancer Institute (NCI)
PI×7
Aaron S Mansfield
Rare Disease / Clinical Research
Alliance for Clinical Trials in Oncology
PI×3 3
Andrew M Blakely, M.D., STNA
Rare Disease / Clinical Research
National Cancer Institute (NCI)
COLUMBUS, OH
PI×5
Shivaani Kummar, MD
Rare Disease / Clinical Research
NCI - Medical Oncology Branch
PORTLAND, OR
PI×6
Nina Merchant
Rare Disease / Clinical Research
Medicenna Therapeutics
PI×1
Karen Chagin, MD, M.D
Rare Disease / Clinical Research
Context Therapeutics Inc.
PHILADELPHIA, PA
PI×1
Dean Fennell
Rare Disease / Clinical Research
University of Leicester
PI×2
Lee M. Krug, MD, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×2 1
Lucas Sideris, MD
Rare Disease / Clinical Research
Maisonneuve-Rosemont Hospital
PI×1 1
Intidhar Labidi-Galy, MD, PhD
Rare Disease / Clinical Research
University Hospital, Geneva
PI×1
Marianna Koczywas, MD
Rare Disease / Clinical Research
City of Hope Comprehensive Cancer Center LAO
DUARTE, CA
PI×2
Yi-Tong Liu
Rare Disease / Clinical Research
Beijing Shijitan Hospital
3
Yu-Bin Fu
Rare Disease / Clinical Research
Beijing Shijitan Hospital
3
Vahan Kepenekian
Rare Disease / Clinical Research
Surgical Oncology Department
3
Xuemei Du
Rare Disease / Clinical Research
Beijing Shijitan Hospital
2
Zhiran Yang
Rare Disease / Clinical Research
Beijing Shijitan Hospital
2
Xin-Bao Li
Rare Disease / Clinical Research
Beijing Shijitan Hospital
2
Frederic Marchal
Rare Disease / Clinical Research
Institut de Cancérologie de Lorraine
2
Laurent Villeneuve
Rare Disease / Clinical Research
Faculté de Médecine Lyon-Sud
2
Yi Wang
Rare Disease / Clinical Research
Fifth Medical Center of Chinese PLA General Hospital
PI×1 2
Sabine Hazan
ProgenaBiome
VENTURA, CA
QC-verified PI×8
Zhi-Ran Yang
Rare Disease / Clinical Research
Beijing Shijitan Hospital
3
Xin-Li Liang
Rare Disease / Clinical Research
Beijing Shijitan Hospital
4
Rui Yang
Rare Disease / Clinical Research
Beijing Shijitan Hospital
4
Yan-Dong Su
Rare Disease / Clinical Research
Beijing Shijitan Hospital
6
He-Liang Wu
Rare Disease / Clinical Research
Beijing Shijitan Hospital
6
Ru Ma
Rare Disease / Clinical Research
Beijing Shijitan Hospital
6
Garrett Nash, M.D
Memorial Sloan Kettering Cancer
NEW YORK, NY
QC-verified PI×1
Yongkun Sun
Cancer Institute and Hospital, Chinese Academy of Medical SciencesCancer
QC-verified PI×1
Luana Calabro'
Medical Oncology and Immunotherapy Division, Univeristy Hospital os Siena, Siena, Italy
QC-verified PI×1
Olivia SGARBURA
Institut régional du Cancer de Montpellier
QC-verified PI×1
Giulia Pasello
Istituto Oncologico Veneto IOV IRCCS
QC-verified PI×2

More about Malignant peritoneal mesothelioma